Low rate of long-lasting remissions after successful treatment of immune thrombocytopenic purpura with rituximab.

Schweizer, Christof

Low rate of long-lasting remissions after successful treatment of immune thrombocytopenic purpura with rituximab. [electronic resource] - Annals of hematology Oct 2007 - 711-7 p. digital

Publication Type: Journal Article

1432-0584

10.1007/s00277-007-0335-1 doi


Acute Disease
Adolescent
Adult
Aged
Aged, 80 and over
Antibodies, Monoclonal--administration & dosage
Antibodies, Monoclonal, Murine-Derived
Autoantibodies--immunology
Female
Follow-Up Studies
Humans
Immunologic Factors--administration & dosage
Male
Middle Aged
Platelet Count
Platelet Membrane Glycoproteins--immunology
Purpura, Thrombocytopenic, Idiopathic--blood
Remission Induction
Retrospective Studies
Rituximab
Splenectomy
Time Factors